Last edition
News about "Vipul Jairath"
Teva and Sanofi Report Long-Term Data for Duvakitug
Teva and Sanofi have reported positive phase 2b data for duvakitug, showing sustained clinical remission and response in Ulcerative Colitis and Crohn’s Disease.
Vipul Jairath | 23/10/2026 | By News Bureau
ENTYVIO Trial Shows Disease Clearance Benefits in Ulcerative Colitis
The first Ulcerative Colitis treat-to-target trial shows ENTYVIO (vedolizumab) delays disease-related complications with disease clearance versus symptomatic remission.
Vipul Jairath | 22/10/2026 | By News Bureau | 128
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy